Cancer Res 64 : 236242 Girnita L, Girnita A, Brodin B, Xie Y, Nilsson G, Dricu A, Lundeberg J, Wejde J, Bartolazzi A, Wiman KG, Larsson O (2000) Increased expression of insulin-like growth factor I receptor in malignant cells expressing aberrant p53: functional impact
While it has been in research for over 20 years, it has recently gained a second life thanks to the massive public interest in peptide therapy and the rise of GLP-1 medications.
Florez, Andrew T
Across 50 or 150 patients, this becomes a significant revenue gap
Apr 2014;80(4):206-13
Bryan Doonan and his experienced team, the clinic has expanded to include advanced weight management treatments like GLP-1 therapy